Savara to Present at the Stifel 2019 Healthcare Conference
November 12 2019 - 4:05PM
Business Wire
Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, will
be presenting at the Stifel 2019 Healthcare Conference on Tuesday,
November 19, 2019 at 3:00 PM ET / 12:00 PM PT at the Lotte New York
Palace Hotel. Rob Neville, Savara’s Chief Executive Officer, will
represent the Company at the conference.
Interested parties can access a live audio webcast on the
Investors page of the Savara website at
www.savarapharma.com/investors/events-presentations/. Archived
presentations will be available on Savara’s website for 90 days
following the events.
About Savara
Savara is an orphan lung disease company. Savara’s pipeline
comprises Molgradex, an inhaled granulocyte-macrophage
colony-stimulating factor (GM-CSF) in Phase 3 development for
autoimmune pulmonary alveolar proteinosis (aPAP), in Phase 2a
development for nontuberculous mycobacterial (NTM) lung infection
in both non-cystic fibrosis (CF) and CF-affected individuals with
chronic NTM lung infection; and AeroVanc, a Phase 3-stage inhaled
vancomycin for treatment of persistent methicillin-resistant
Staphylococcus aureus (MRSA) lung infection in CF. Savara’s
strategy involves expanding its pipeline of potentially
best-in-class products through indication expansion, strategic
development partnerships and product acquisitions, with the goal of
becoming a leading company in its field. Savara’s management team
has significant experience in orphan drug development and pulmonary
medicine, identifying unmet needs, developing and acquiring new
product candidates, and effectively advancing them to approvals and
commercialization. More information can be found at
www.savarapharma.com. (Twitter: @SavaraPharma, LinkedIn:
www.linkedin.com/company/savara-pharmaceuticals/)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191112005108/en/
Savara Inc. IR & PR Anne Erickson
(anne.erickson@savarapharma.com) (512) 851-1366
Savara (NASDAQ:SVRA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Savara (NASDAQ:SVRA)
Historical Stock Chart
From Apr 2023 to Apr 2024